RAP80 regulates epithelial-mesenchymal transition related with metastasis and malignancy of cancer

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Epithelial-mesenchymal transition (EMT) is linked to cancer invasion and metastasis.
• The interplay between DNA damage response and EMT in cancer is a growing area of research.

Purpose of the Study:

• To investigate the role of RAP80, a DNA damage response regulator, in controlling EMT.
• To elucidate the molecular mechanisms by which RAP80 influences EMT and cancer progression.

Main Methods:

• RAP80 knockdown in cancer cells.
• Analysis of EMT-associated morphological changes and tumor sphere formation.
• Investigation of the ZEB1/miR200c regulatory axis.
• Assessment of E-cadherin, p16, and p21 expression.
• In vivo metastasis assays.
• Correlation analysis of RAP80 expression with patient survival data.

Main Results:

• RAP80 downregulation induced EMT-like changes and increased tumor sphere formation.
• RAP80 deficiency led to increased ZEB1 protein and decreased miR200c expression, activating EMT signaling.
• Knockdown of RAP80 resulted in decreased E-cadherin, p16, and p21 expression.
• RAP80 knockdown cells exhibited significantly increased lung metastasis and malignancy in vivo.
• Lower RAP80 expression correlated with poorer survival rates in lung adenocarcinoma and breast cancer patients.

Conclusions:

• RAP80 acts as a crucial suppressor of EMT-induced metastasis and cancer malignancy.
• RAP80 plays a vital role in maintaining DNA integrity and preventing cancer progression.
• Targeting RAP80 could offer a therapeutic strategy for inhibiting cancer metastasis.